Surgery vs radiotherapy in the management of biopsy Gleason score 9-10 prostate cancer and the risk of mortality

D Tilki, MH Chen, J Wu, H Huland, M Graefen… - JAMA …, 2019 - jamanetwork.com
Importance It is unknown how treatment with radical prostatectomy (RP) and adjuvant
external beam radiotherapy (EBRT), androgen deprivation therapy (ADT), or both …

[HTML][HTML] Predicting prostate cancer specific-mortality with artificial intelligence-based Gleason grading

E Wulczyn, K Nagpal, M Symonds, M Moran… - Communications …, 2021 - nature.com
Background Gleason grading of prostate cancer is an important prognostic factor, but suffers
from poor reproducibility, particularly among non-subspecialist pathologists. Although …

Declining use of radiotherapy for adverse features after radical prostatectomy: results from the National Cancer Data Base

HM Sineshaw, PJ Gray, JA Efstathiou, A Jemal - European urology, 2015 - Elsevier
Background Patterns of postoperative radiotherapy (RT) use in prostate cancer (PCa) after
the publication of major randomized trials have not been well characterized. Objective To …

[HTML][HTML] Adjuvant radiotherapy after salvage lymph node dissection because of nodal relapse of prostate cancer versus salvage lymph node dissection only

HC Rischke, W Schultze-Seemann, G Wieser… - Strahlentherapie und …, 2015 - infona.pl
Background Nodal pelvic/retroperitoneal recurrent prostate cancer (PCa) after primary
therapy can be treated with salvage lymph node dissection (salvage-LND) in order to delay …

[HTML][HTML] Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy

MJ Roberts, A Morton, N Papa, A Franklin… - European Journal of …, 2022 - Springer
Purpose The prognostic value of PSMA intensity on PSMA PET/CT due to underlying
biology and subsequent clinical implications is an emerging topic of interest. We sought to …

Genomic classifier augments the role of pathological features in identifying optimal candidates for adjuvant radiation therapy in patients with prostate cancer …

D Dalela, M Santiago-Jiménez, K Yousefi… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Despite documented oncologic benefit, use of postoperative adjuvant radiotherapy
(aRT) in patients with prostate cancer is still limited in the United States. We aimed to …

Noninferiority of hypofractionated vs conventional postprostatectomy radiotherapy for genitourinary and gastrointestinal symptoms: the NRG-GU003 phase 3 …

MK Buyyounouski, SL Pugh, RC Chen, MJ Mann… - JAMA …, 2024 - jamanetwork.com
Importance No prior trial has compared hypofractionated postprostatectomy radiotherapy
(HYPORT) to conventionally fractionated postprostatectomy (COPORT) in patients primarily …

Very early salvage radiotherapy improves distant metastasis-free survival

A Abugharib, WC Jackson, V Tumati, RT Dess… - The Journal of …, 2017 - auajournals.org
Purpose: Early salvage radiotherapy following radical prostatectomy for prostate cancer is
commonly advocated in place of adjuvant radiotherapy. We aimed to determine the optimal …

Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both

SL Jarosek, BA Virnig, H Chu, SP Elliott - European urology, 2015 - Elsevier
Background Prostate cancer is the second most common cancer in men and has high
survivorship, yet little is known about the long-term risk of urinary adverse events (UAEs) …

RETRACTED: Recommandations françaises du Comité de Cancérologie de l'AFU–Actualisation 2018–2020: cancer de la prostate

F Rozet, C Hennequin, JB Beauval, P Beuzeboc… - Progrès en urologie, 2018 - Elsevier
Author links open overlay panel F. Rozet ab, C. Hennequin ac, J.-B. Beauval ad, P.
Beuzeboc ae, L. Cormier af, G. Fromont-Hankard ag, P. Mongiat-Artus ah, G. Ploussard ai …